KPV + GHK-Cu
aka kpvghkcu
Healing & Recovery
Mechanism
Grey-market vendor blend combining KPV (Lys-Pro-Val, the C-terminal tripeptide of α-MSH) and GHK-Cu (a copper tripeptide). This blend is not clinically validated; no human trials of the combination exist, and evidence for each component is extrapolated from preclinical or topical studies.
Identification
| Typical dose | GHK-Cu: 1–2 mg/day subcutaneous; KPV: 500 mcg–1 mg/day subcutaneous (research use; exact blend ratios vary by vendor, e.g. 50 mg GHK-Cu / 20 mg KPV vials) |
|---|---|
| Half-life | KPV: ~1–2 hours; GHK-Cu: ~2–4 hours (both estimated, rapid peptidase degradation) |
Vendors selling KPV + GHK-Cu
| Vendor | Size | Price | Listed purity | Trust |
|---|---|---|---|---|
| Crush Research | 60 mg | — | — | 95 |
| NG Peptide | — | $65.00 | — | — |
Research
No citations on file yet.